1,425 reports of this reaction
5.0% of all DOLUTEGRAVIR SODIUM reports
#1 most reported adverse reaction
PAIN is the #1 most commonly reported adverse reaction for DOLUTEGRAVIR SODIUM, manufactured by ViiV Healthcare Company. There are 1,425 FDA adverse event reports linking DOLUTEGRAVIR SODIUM to PAIN. This represents approximately 5.0% of all 28,565 adverse event reports for this drug.
Patients taking DOLUTEGRAVIR SODIUM who experience pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PAIN is moderately reported among DOLUTEGRAVIR SODIUM users, representing a notable but not dominant share of adverse events.
In addition to pain, the following adverse reactions have been reported for DOLUTEGRAVIR SODIUM:
The following drugs have also been linked to pain in FDA adverse event reports:
PAIN has been reported as an adverse event in 1,425 FDA reports for DOLUTEGRAVIR SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
PAIN accounts for approximately 5.0% of all adverse event reports for DOLUTEGRAVIR SODIUM, making it one of the most commonly reported side effect.
If you experience pain while taking DOLUTEGRAVIR SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.